Gastrointestinal stromal tumors: A clinicopathologic and immunohistochemical study of 136 cases

Pathology and Oncology Research

Volumn 11, Issue 1, 2005, Pages 11-21

  Orosz, Zsolt ^a   Tornóczky, Tamás ^b   Sápi, Zoltán ^c  

^a NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

^b UNIVERSITY OF PÉCS   (Hungary)

^c ST JOHN'S HOSPITAL   (Hungary)

Author keywords

c kit; CD117; Gastrointestinal stromal tumor (GIST); Inflammatory fibroid polyp; Leiomyoma; Leiomyosarcoma; Schwannoma

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CALDESMON; CD34 ANTIGEN; CYTOKERATIN; DESMIN; PROTEIN S 100; STEM CELL FACTOR RECEPTOR; VIMENTIN;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; COLON TUMOR; FEMALE; GASTROINTESTINAL STROMAL TUMOR; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEIOMYOMA; LEIOMYOSARCOMA; MAJOR CLINICAL STUDY; MALE; MITOSIS INDEX; NEURILEMOMA; PROGNOSIS; RECTUM TUMOR; SMALL INTESTINE TUMOR; STOMACH TUMOR; TUMOR LOCALIZATION; TUMOR RECURRENCE;

EID: 18444385858     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03032400     Document Type: Article

References (36)

1. Ceballos KM, Nielsen GP, Selig MK, O'Cornell JX: Is anti-h-caldesmon useful for distinguishing smooth muscle and myofibroblastic tumors? An immunohistochemical study. Am J Clin Pathol 114: 746-753, 2000
2. Corless CL, Fletcher JA, Heinrich MC: Biology of gastrointestinal stromal tumors. J Clin Oncol 22: 3813-3825, 2004
3. Daum O, Hes O, Vanecek T, et al: Vanek's tumor (inflammatory fibroid polyp). Report of 18 cases and comparison with three cases of original Vanek's series. Mod Pathol 16:366-375, 2003
4. DeMatteo RP, Lewis JJ, Leung D, et al: Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg 231:51-58, 2000
5. de Silva CM, Reid R: Gastrointestinal stromal tumors (GIST): C-kit mutations, CD117 expression, differential diagnosis and targeted cancer therapy with Imatinib. Pathol Oncol Res 9:13-19, 2003
6. Eckhardt S, Pápai Zs, Bodoky Gy, et al: Az imatinib kezelés hatása gastrointestinalis stroma eredetu daganatokban [Effect of imatinib treatment of gastrointestinal stromal tumors] Orv Hetil 144:2207-2212, 2003
7. Emile JF, Theou N, Tabone S, et al: Clinicopathologic, phenotypic, and genotypic characteristics of gastrointestinal mesenchymal tumors. Clin Gastroenterol Hepatol 2:597-605, 2004
8. Fletcher CDM, Berman JJ, Corless C, et al: Diagnosis of gastrointestinal stromal tumors: A consensus approach. Hum Pathol 33: 459-465, 2002
9. Fujimoto Y, Nakanishi Y, Yoshimura K, Shimoda T: Clinicopathologic study of primary malignant gastrointestinal stromal tumor of the stomach, with special reference to prognostic factors: analysis of results in 140 surgically resected patients. Gastric Cancer 6: 39-48, 2003
10. Greenson JK: Gastrointestinal stromal tumors and other mesenchymal lesions of the gut. Mod Pathol 16: 366-375, 2003
11. Hasegawa T, Matsuno Y, Shimoda T, Hirohashi S: Gastrointestinal stromal tumor: consistent CD117 immunostaining for diagnosis, and prognostic classification based on tumor size and MIB-1 grade. Hum Pathol 33: 669-676, 2002
12. Hirota S, Isozaki K, Moriyama Y et al: Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 279:577-580, 1998
13. Hjermstad BM, Sobin LH, Helwig EB: Stromal tumors of the gastrointestinal tract: myogenic or neurogenic? Am J Surg Pathol 11:383-386, 1987
14. Joensuu H, Roberts PJ, Sarlomo-Rikala M, et al: Effect of the tyrosine kinase inhibitor ST1571 in a patient with a metastatic gastrointestinal stromal tumor. N Engl J Med. 344:1052-1056, 2001
15. Kindblom LG, Remotti HE, Aldenborg F, Meis-Kindblom JM: Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am J Pathol 152: 1259-1269, 1998
16. Kwon MS, Lee SS, Ahn GH: Schwannomas of the gastrointestinal tract: clinicopathological features of 12 cases including a case of esophageal tumor compared with those of gastrointestinal stromal tumors and leiomyomas of the gastrointestinal tract. Pathol Res Pract 198: 605-613, 2002
17. Lasota J, Wasag B, Dansonka-Mieszkowska A, et al: Evaluation of NF2 and NF1 tumor suppressor genes in distinctive gastrointestinal nerve sheath tumors traditionally diagnosed as benign schwannomas: s study of 20 cases. Lab Invest. 83: 1361-71, 2003
18. Lee JR, Joshi V, Griffin JW Jr, et al: Gastrointestinal autonomic nerve tumor: immunohistochemical and molecular identity with gastrointestinal stromal tumor. Am J Surg Pathol 25: 979-987, 2001
19. Mazur MT, Clark HB. Gastric stromal tumors: reappraisal of histogenesis. Am J Surg Pathol 7:507-519, 1983
20. Medeiros F, Corless CL, Duensing A, et al: KIT-negative gastrointestinal stromal tumors: proof of concept and therapeutic implications. Am J Surg Pathol 28:889-894, 2004
21. Miettinen M, Furlong M, Sarlomo-Rikala M, et al: Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the rectum and anus: a clinicopathologic, immunohistochemical, and molecular genetic study of 144 cases. Am J Surg Pathol 25:1121-1133, 2001
22. Miettinen M, Kopczynski J, Makhlouf HR, et al: Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the duodenum: a clinicopathologic, immunohistochemical, and molecular genetic study of 167 cases. Am J Surg Pathol 27:625-641, 2003
23. Miettinen M, Lasota J: Gastrointestinal stromal tumors - definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch 438:1-12, 2001
24. Miettinen M, Shekitka KM, Sobin LH: Schwannomas in the colon and rectum: a clinicopathologic and immunohistochemical study of 20 cases. Am J Surg Pathol 25: 846-855, 2001
25. Miettinen M, Sobin LH, Sarlomo-Rikala M: Immunohistochemical spectrum of GISTs at different sites a their differential diagnosis with a reference to CD117 (KIT). Mod Pathol 13: 1134-1142, 2000
26. Miettinen M, Virolainen M, Sarlomo-Rikala M: Gastrointestinal stromal tumors: Value of CD34 antigen in their identification and separation from true leiomyomas and schwannomas. Am J Surg Pathol 19:207-216, 1995
27. Mikhael Al, Bacchi CE, Zarbo RJ, et al: CD34 expression in stromal tumors of the gastrointestinal tract. Appl Immunohistochem 2:89-93, 1994
28. Reith, JD, Goldblum JR, Lyles RH, Weisx SW: Extragastrointestinal (soft tissue) stromal tumors: Analysis of 48 cases with emphasis on histologic predictors of outcome. Mod Pathol 13:577-585, 2000
29. Rudolph P, Chiaravalli AM, Pauser U, et al: Gastrointestinal mesenchymal tumors - immunophenotypic classification and survival analysis. Virchows Arch 441: 238-248, 2002
30. Sápi Z, Kovács RB, Bodó M: Gastrointestinal stromal tumors. Observations on the basis of 29 cases Orv Hetil 142: 2479-2485, 2001
31. Stout AP: Bizarre smooth muscle tumors of the stomach. Cancer 15:400-409, 1962
32. Tornóczky T, Kövér E, Pajor L: Frequent occurrence of low grade cases among metastatic gastrointestinal stromal tumours J Clin Pathol 56: 363-367, 2003
33. West RB, Corless CL, Chen X, et al: The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status. Am J Pathol 165: 107-113, 2004
34. Wong NA, Young R, Malcomson RD, et al: Prognostic indicators for gastrointestinal stromal tumours: a clinicopathological and immunohistochemical study of 108 resected cases of the stomach. Histopathology. 43:118-126, 2003
35. Yamaguchi U, Hasegawa T, Masuda T, et al: Differential diagnosis of gastrointestinal stromal tumor and other spindle cell tumors in the gastrointestinal tract based on immunohistochemical analysis. Virchows Arch 445:142-150, 2004
36. Yantiss RK, Spiro IJ, Compton CC, Rosenberg AE: Gastrointestinal stromal tumor versus intra-abdominal fibromatosis of the bowel wall: a clinically important differential diagnosis. Am J Surg Pathol 24:947-957, 2000